CJC-1295 (DAC) — Growth Hormone Releasing Peptide for Research (UK)

CJC-1295 (with DAC) is a research-grade peptide widely studied for its ability to stimulate growth hormone (GH) secretion and explore anabolic, metabolic, and cellular repair pathways. In the United Kingdom, it is used in controlled in-vitro and preclinical laboratory studies to investigate GH regulation, tissue repair mechanisms, and metabolic signalling.

Supplied as a lyophilised peptide powder, CJC-1295 (DAC) ensures stable handling, accurate dosing, and reproducible experimental outcomes, making it suitable for advanced research in endocrinology, metabolism, and cellular regeneration studies.

Key Facts About CJC-1295 (DAC)

Research Uses

• Investigating growth hormone (GH) release pathways
• Metabolic regulation and endocrine signalling studies
• Tissue repair, cellular recovery, and regeneration research
• In-vitro and preclinical models of GH activity
• Comparative studies of anabolic and peptide-mediated signalling pathways

Advantages

• High laboratory-grade purity for reproducible experimental outcomes
• Stable formulation under standard laboratory storage conditions
• Suitable for diverse experimental designs in endocrinology and metabolic research
• Supports precise investigation of tissue repair and regeneration mechanisms
• Ideal for advanced studies in GH signalling and cellular biology

Why Choose CJC-1295 (DAC) in the UK?

Researchers in the United Kingdom select CJC-1295 (DAC) for its stability, high-quality formulation, and relevance in growth hormone and metabolic research. Its lyophilised form ensures consistent experimental performance, making it a reliable tool for laboratories investigating GH pathways, anabolic signalling, and tissue regeneration processes.

CJC-1295 (DAC) is intended strictly for laboratory and scientific research use only, supporting studies in endocrinology, metabolic regulation, and cellular regeneration.